Frazier Healthcare Partners Raises $986 Million Biotech Venture Fund
Chris Miller, a partner and leader of Troutman Pepper's Emerging Companies and Venture Capital team, is quoted in the WSJ Pro Venture Capital article, " Frazier Healthcare Partners Raises $986 Million Biotech Venture Fund."
But biotech financings have since slowed as IPOs have stalled and the stock market has slumped. That has led biotech venture investors to be more selective and seek out bargains, said Chris Miller, a partner with law firm Troutman Pepper Hamilton Sanders LLP.